CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 990 enrolled
Drug / intervention
Non-pneumatic Anti-shock Garment (NASG)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00305253
NCT00305253Phase 2Completed
CompareCT.gov

Efficacy Study of the Non-Pneumatic Anti-Shock Garment (NASG) in Egypt

University of California, San Francisco·interventional·Posted Mar 21, 2006·Updated May 14, 2013

In Brief

A Phase 2 clinical trial evaluating Non-pneumatic Anti-shock Garment (NASG) for Hypovolemic Shock and Hemorrhage. Completed, enrolled 990 participants across 2 sites.

Detailed Summary

This study will test the efficacy of the NASG on women suffering from obstetric hemorrhage as compared to hemorrhaging women who do not receive the NASG.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypovolemic Shock, Hemorrhage
CountriesEgypt
CollaboratorsMacArthur Foundation

Timeline

Phase 2CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 21, 2006
Enrollment StartApr 1, 2006
Primary CompletionJun 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 20.3 years ago

Interventions

Non-pneumatic Anti-shock Garment (NASG)device

In the Post-Intrevention phase of the study, the NASG will be used when a patient meets the study criteria.